Literature DB >> 17061129

Simultaneous evaluation of myocardial blood flow, cardiac function and lung water content using [15O]H2O and positron emission tomography.

Alexandru Naum1, Helena Tuunanen, Erik Engblom, Vesa Oikonen, Hannu Sipilä, Patricia Iozzo, Pirjo Nuutila, Juhani Knuuti.   

Abstract

PURPOSE: This study sought to evaluate an imaging approach using [15O]H2O and positron emission tomography (PET) for simultaneous assessment of myocardial perfusion, cardiac function and lung water content as a potential indicator of pulmonary oedema.
METHODS: Twenty-six subjects divided into two groups (group I, 13 patients with idiopathic dilated cardiomyopathy; group II, 13 healthy volunteers) underwent dynamic PET scanning after intravenous infusion of approximately 995 MBq [15O]H2O. In both groups, echocardiograms were performed after the PET studies. From the dynamic [15O]H2O data, lung water content (LWC) at equilibrium, myocardial blood flow (MBF), cardiac output (CO), stroke volume (SV) and stroke volume indexes (SVI) using the indicator dilution principle were determined.
RESULTS: LWC was 18% (p = 0.038) higher in patients than in controls. Global MBF did not differ significantly between the groups, but regional MBF values were significantly lower (p < 0.05) in the anterior and septal walls in the patient group. The results of the Passing-Bablok regression indicated the absence of a systematic difference between the two techniques. Bland-Altman analysis performed for each group (patients vs healthy controls) showed a non-significant bias (p > 0.1) of -0.02 +/- 0.82 vs -0.05 +/- 0.54 l/min (CO), -1.44 +/- 14.31 vs 1.70 +/- 10.56 ml/beat (SV) and 0.47 +/- 6.21 vs 0.30 +/- 5.02 ml/beat/m2 (SVI). The 95% limits of agreement were -1.62 to 1.59 vs -1.11 to 1.01 l/min (CO), -26.61 to 29.49 vs -22.39 to 18.99 ml/beat (SV) and -11.69 to 12.88 vs -9.53 to 10.14 ml/beat/m2 (SVI). Right ventricular CO was increased by 33% (p = 0.014) in the patient group as compared with normal controls.
CONCLUSION: Our results demonstrate that additional analysis of cardiac function and lung water content are feasible from the dynamic cardiac [15O]H2O PET studies acquired for myocardial perfusion. The parameters appear to work as expected. Further studies are warranted to elucidate the clinical value of these new parameters.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061129     DOI: 10.1007/s00259-006-0259-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  20 in total

1.  Regional lung water measurements with PET: accuracy, reproducibility, and linearity.

Authors:  M Velazquez; J Haller; T Amundsen; D P Schuster
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

2.  Measurement of cardiac output with first-pass determination during rubidium-82 PET myocardial perfusion imaging.

Authors:  E Q Chen; W J MacIntyre; F M Fouad; R C Brunken; R T Go; C O Wong; G B Saha; K Dorosti; M Razavi; R Armstrong
Journal:  Eur J Nucl Med       Date:  1996-08

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Myocardial perfusion and perfusion reserve in endurance-trained men.

Authors:  Kari K Kalliokoski; Pirjo Nuutila; Hanna Laine; Matti Luotolahti; Tuula Janatuinen; Olli T Raitakari; Teemu O Takala; Juhani Knuuti
Journal:  Med Sci Sports Exerc       Date:  2002-06       Impact factor: 5.411

5.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

6.  Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography.

Authors:  H Iida; C G Rhodes; R de Silva; L I Araujo; P M Bloomfield; A A Lammertsma; T Jones
Journal:  J Nucl Med       Date:  1992-09       Impact factor: 10.057

7.  Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan.

Authors:  F Hermansen; J Ashburner; T J Spinks; J S Kooner; P G Camici; A A Lammertsma
Journal:  J Nucl Med       Date:  1998-10       Impact factor: 10.057

8.  Simultaneous cardiac output and regional myocardial perfusion determination with PET and nitrogen 13 ammonia.

Authors:  Jens D Hove; Klaus F Kofoed; Hsiao M Wu; Søren Holm; Lars Friberg; Christian Meyer; Jan Aldershvile; Birger Hesse; Henning Kelbaek
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

9.  The measurement of lung water.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

Review 10.  Positron emission tomography for quantitation of myocardial perfusion.

Authors:  Ornella E Rimoldi; Paolo G Camici
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

View more
  3 in total

Review 1.  Lipid Use and Misuse by the Heart.

Authors:  P Christian Schulze; Konstantinos Drosatos; Ira J Goldberg
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

2.  Stroke volume measurements with first-pass dynamic positron emission tomography: comparison with cardiovascular magnetic resonance.

Authors:  Paul Knaapen; Mark Lubberink; Luuk J Rijzewijk; Rutger W van der Meer; Michiel Unger; Tjeerd Germans; Jeroen J Bax; Jan W A Smit; Hildo J Lamb; Albert C van Rossum; Michaela Diamant; Frans C Visser; Adriaan A Lammertsma
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

3.  Automatic extraction of forward stroke volume using dynamic PET/CT: a dual-tracer and dual-scanner validation in patients with heart valve disease.

Authors:  Hendrik Johannes Harms; Lars Poulsen Tolbod; Nils Henrik Stubkjær Hansson; Tanja Kero; Lovisa Holm Orndahl; Won Yong Kim; Tomas Bjerner; Kirsten Bouchelouche; Henrik Wiggers; Jørgen Frøkiær; Jens Sörensen
Journal:  EJNMMI Phys       Date:  2015-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.